Immuno-oncology is often portrayed as having less severe side effects than chemotherapy, but patients need to be aware that it does carry some risks, said Debra L. Madden, cancer research advocate and patient representative. Patients should not hesitate to report any adverse effects to their doctor.
Immuno-oncology is often portrayed as having less severe side effects than chemotherapy, but patients need to be aware that it does carry some risks, said Debra L. Madden, cancer research advocate and patient representative. Patients should not hesitate to report any adverse effects to their doctor.
Transcript (slightly modified)
Why do patients need to be educated on the risks of immuno-oncology?
The immuno-oncology agents, they may well have different side effects than the typical side effects associated with chemotherapy, for example. There has been a lot of information in the popular media talking about the promise of immuno-oncologic drugs, how it’s such an important breakthrough, and that is true. However, patients do need to understand really the context about how some of this information is being presented.
Often times in the media you’ll see them saying that if you’re on immuno-oncology drugs, the side effects aren’t going to be nearly as severe as what you would experience with chemotherapy or even some targeted agents. But what they’re not saying is that some patients may go on to experience a unique spectrum of adverse effects that are essentially autoimmune in nature, because if your immune system is continuing to act against the tumor, ultimately it’s possible that healthy tissues may also be affected.
So essentially, patients need to understand that if this does happen, it can affect any bodily system. I once heard a clinician say it can cause “any-itis.” So it can affect the bone marrow, it can affect the liver, dermatologic findings are most common. And no, it doesn’t happen with every patient, and fortunately it’s relatively rare and infrequent, and it can be treated. But, folks need to understand this going in, they need to understand the potential benefits as well as the potential harms, and they also need to understand the importance of being very vigilant and reporting any symptoms that may be suggestive of these types of autoimmune findings to their doctors.
A lot of times patients are worried that, “Oh, I don’t want to burden the doctor. I feel like I’m reporting every single ache and pain.” With these agents, it’s very important that you report everything that you’re experiencing, because it’s very possible the doctor might need to see you to rule out whether it is indeed one of these adverse effects in this unique spectrum.
Gaps in Access to Cancer Care Resources May Contribute to Racial, Ethnic Disparities
December 1st 2023Researchers found that core oncology services were less likely to be available at hospitals serving racial and ethnic minority groups compared with other hospitals in the United States.
Read More
In this interview with The American Journal of Managed Care®, Katie Queen, MD, addresses the complexity of obesity as a medical condition, pivoting to virtual care while ensuring that patients who lived in a rural location continued to receive adequate care, and the importance of integrating awareness of obesity and chronic disease prevention into local food culture.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen